Marcel R.M. van den Brink

Marcel R.M. van den Brink

Marcel R.M. van den Brink is a prominent physician-scientist known for his contributions to the field of hematology and oncology. He is particularly recognized for his research on hematopoietic stem cell transplantation and graft-versus-host disease (GVHD).

Education and Career

Dr. van den Brink received his medical degree from the University of Leiden in the Netherlands. He completed his residency in internal medicine at the Leiden University Medical Center. Following this, he pursued a fellowship in hematology and oncology at the National Institutes of Health (NIH) in the United States.

Currently, Dr. van den Brink is the Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. He is also a Professor of Medicine at Weill Cornell Medical College.

Research Contributions

Dr. van den Brink's research focuses on improving the outcomes of hematopoietic stem cell transplantation. His work has significantly advanced the understanding of graft-versus-host disease, a common complication of bone marrow transplantation.

He has published extensively on the role of the immune system in cancer and transplantation. His studies have explored the mechanisms of immune reconstitution and the development of novel strategies to prevent and treat GVHD.

Awards and Honors

Dr. van den Brink has received numerous awards for his contributions to medical research. He is a recipient of the American Society of Hematology's Scholar Award and has been recognized by the American Association for Cancer Research.

External Links

• [Memorial Sloan Kettering Cancer Center Profile](https://www.mskcc.org/research-areas/labs/marcel-van-den-brink)
• [PubMed Publications](https://pubmed.ncbi.nlm.nih.gov/?term=Marcel+R.M.+van+den+Brink)